Aptevo Therapeutics Inc. (APVO) Institutional Ownership

What the institutions did with APVO last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.

Managers reporting

9

filed a 13F this quarter

Managers holding

9

+1 on the quarter

Buyers

2

1 opened new

Sellers

2

0 sold out entirely

Buyer share

50.0%

of managers who traded it

Breadth

+0.0

net buyers, as a share of those trading

Only 9 managers reported a position this quarter, so the percentages above describe a very small sample.

Largest holders

Manager	Shares	% of reported
GSA CAPITAL PARTNERS LLP	21.5K	42.7%
VANGUARD CAPITAL MANAGEMENT LLC	12.7K	25.2%
GEODE CAPITAL MANAGEMENT, LLC	10.8K	21.5%
VANGUARD FIDUCIARY TRUST CO	4.1K	8.2%
UBS Group AG	730	1.4%
OSAIC HOLDINGS, INC.	360	0.7%
SBI Securities Co., Ltd.	109	0.2%
BARCLAYS PLC	31	0.1%
DANSKE BANK A/S	1	0.0%

Largest changes

Manager	Action	Previous	Current	Change
UBS Group AG	Reduced	3.4K	730	-2.7K
GEODE CAPITAL MANAGEMENT, LLC	Reduced	13.3K	10.8K	-2.5K
GSA CAPITAL PARTNERS LLP	Increased	19.6K	21.5K	+1.9K
BARCLAYS PLC	New	0	31	+31

13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.